Skip to main content
    O

    Oculis Holding AG Ordinary shares (OCS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.51
    -0.12 (-1.57%)

    Market Cap: $425.11M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Oculis Holding AG Ordinary shares (OCS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Oculis Holding AG Ordinary shares (OCS) has a market cap of $425.11M. It kept -1157669.73% of revenue as net income over the last 12 months. Revenue fell 98.61% over the last 12 months from the 12 months before.

    Total Valuation

    Market Cap$425.11M
    Latest price (Nov 17, 2026)$7.51

    Key Dates

    Last Earnings DateNov 3, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.89% in the quarter ended Sep 30, 2026 and grew 21.59% a year over 2 years.

    Shares Outstanding61.82M
    Shares Change (YoY)+17.36%
    Shares Change (QoQ)+0.89%
    Share Count Growth (2Y CAGR)+21.59%

    Valuation Ratios

    P/B Ratio1.9x
    P/TBV Ratio2.0x

    Price Statistics

    The stock is down 61.68% over 52 weeks and trades 12.27% below its 50-day average.

    Beta (1Y)1.06
    52-Week Change-61.68%
    1-Month Change+2.60%
    3-Month Change-44.66%
    6-Month Change-73.14%
    Total Return (1Y)-61.68%
    Total Return (3Y CAGR)-8.21%
    Return vs SPY (1Y)-72.63%
    Max Drawdown (1Y)-79.08%
    Max Drawdown (3Y)-79.08%
    Sharpe Ratio (1Y)-1.28
    Correlation with SPY (1Y)0.20
    50-Day Average$8.56
    200-Day Average$17.65
    52-Week Range$6.78 to $34.48
    RSI (14 Days)42.4
    Average Volume (20 Days)305.94K

    Price chart

    Financial Position

    Current assets cover 10.41x current liabilities.

    Current Ratio10.41x
    Quick Ratio10.41x
    Interest Coverage-73.78x

    Returns and Efficiency

    Return on equity is -40.24% and return on assets is -36.16% over the last 12 months.

    Return on Equity (ROE)-40.24%
    Return on Assets (ROA)-36.16%
    Return on Capital Employed (ROCE)-37.92%
    ROA (5Y Average)-65.06%
    ROIC (5Y Average)-82.69%
    Asset Turnover0.00x

    Scores

    OCS has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was CHF 7.00K over the last 12 months.

    RevenueCHF 7.00K
    Revenue Growth (YoY)-98.61%
    Operating IncomeCHF -90.52M
    Pretax IncomeCHF -81.35M
    Net IncomeCHF -81.04M
    EBITDACHF -79.49M
    EBITCHF -80.26M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 89.85% of the CHF 232.32M in total assets.

    Working CapitalCHF 194.18M
    Shareholder EquityCHF 208.75M
    Tangible Book ValueCHF 195.46M
    Total AssetsCHF 232.32M
    Total LiabilitiesCHF 23.57M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash FlowCHF -71.41M
    Depreciation and AmortizationCHF 764.43K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -1293091.53%.

    Operating Margin-1293091.53%
    Pretax Margin-1162195.49%
    Net Margin-1157669.73%
    EBITDA Margin-1135617.49%
    EBIT Margin-1146537.97%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About OCS

    What is OCS's market cap?

    Oculis Holding AG Ordinary shares has a market cap of $425.11M.

    How many shares of OCS are outstanding?

    Oculis Holding AG Ordinary shares has 61.82M shares outstanding. The count is up 17.36% from a year earlier.

    Does OCS pay a dividend?

    No. Oculis Holding AG Ordinary shares does not pay a dividend.